查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1733240

全球电脑辅助诊断市场规模（依显像模式、应用、区域范围）预测（至 2025 年）

Global Computer Aided Diagnosis Market Size By Imaging Modalities, By Application, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

电脑辅助诊断市场规模及预测

2024 年电脑辅助诊断市场规模为 7.9233 亿美元，预计到 2032 年将达到 12.1121 亿美元，2026 年至 2032 年的复合年增长率为 6.01%。

推动全球电脑辅助诊断市场的因素

电脑辅助诊断市场的市场驱动因素可能受到多种因素的影响。这些包括：

技术进步：人工智慧 (AI) 演算法和成像模式（例如 MRI、 电脑断层扫描、X 光）的发展正在提高 CAD 系统的准确性和效率，从而推动其发展。

慢性病盛行率上升：癌症、心血管疾病、神经系统疾病等慢性病盛行率不断上升，需要早期、准确的诊断。 CAD 系统使这成为可能，推动了市场需求。

老龄人口不断增加：随着世界人口老化，需要频繁进行诊断影像的与老龄化相关的疾病变得越来越普遍。 CAD 系统有助于及早诊断和发现此类问题，从而促进市场扩张。

对于非侵入性诊断程序：电脑辅助诊断系统 (CAD) 提供非侵入性诊断选项，减少患者的不适和与侵入性程序相关的潜在问题。这推动了 CAD 技术的应用，尤其是在乳癌检测等领域。

政府融资和倡议：提供资金和鼓励医疗保健基础设施的发展可以增加 CAD 系统的采用，尤其是在新兴经济体。

医疗保健支出不断增长：全球医疗保健支出不断增长，尤其是在已开发国家，这使得医疗机构能够购买电脑辅助诊断 (CAD) 系统等先进的诊断工具。

高效率医疗服务的需求：CAD 系统可减少诊断错误、简化诊断流程并提高医疗专业人员的工作流程效率。 CAD 技术的采用是由更有效率的医疗保健服务的需求所驱动。

教育和宣传宣传活动：有关早期诊断的好处和医学影像处理技术改进的教育宣传活动可以提高患者和医疗保健专业人员对 CAD 系统的接受度。

与电子健康记录(EHR) 系统的整合：透过 CAD 和 EHR 系统的整合实现顺畅的资讯交流和决策将提高资料可存取性和互通性，从而有助于推动市场扩张。

限制全球电脑辅助诊断市场的因素

多种因素可能会对电脑辅助诊断市场造成限制和挑战。具体如下：

投资高：CAD 系统的初始投资通常很高，包括培训、软体和硬体的支出。对于医疗机构来说，高昂的实施成本可能是一个主要障碍，尤其是在较贫穷的国家或较小的机构。

整合挑战：将 CAD 系统与目前的医疗保健基础设施（包括影像存檔和通讯系统 (PACS) 和电子健康记录(EHR)）整合可能很困难且成本高昂。相容性问题和互通性困难可能会降低采用率。

监管障碍：用于医疗诊断的 CAD 系统受到严格的监管，特别是在资料隐私、安全性和有效性方面。获得监管部门核准的过程成本高且耗时，这可能会延迟新创意和新产品的上市。

临床证据有限：儘管 CAD 技术已经取得了进步，但可能没有足够有力的临床证据来支持其在改善患者预后和诊断准确性方面的价值。由于这种不确定性，医疗保健提供者可能不愿意广泛采用 CAD 系统。

依赖专家知识：CAD 系统通常使用由专家创建的资料集训练的演算法。然而，CAD 演算法的准确性和可靠性取决于这些资料集的品质和代表性。这些数据集可能有所不同，尤其是涉及罕见疾病和不同患者群体时。

工作流程中断：将 CAD 系统纳入临床工作流程可能会改变既定程序，而医疗保健专业人员需要接受培训才能正确使用该技术。医疗保健工作者对变革的抵制和对工作流程中断的担忧可能会降低采用率。

资料安全问题：CAD 系统处理大量个人病患数据，引发对资料安全、隐私和潜在违规行为的担忧。对于 CAD 供应商和医疗保健组织来说，确保病患资讯安全并遵守资料保护标准是一项挑战，但却是必要的。

目录

第一章：全球电脑辅助诊断市场简介

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章 电脑辅助诊断的全球市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

第五章。全球显像模式电脑辅助诊断市场

  • 概述
  • 乳房X光摄影
  • 核医学影像
  • 超音波影像
  • 磁振造影
  • 其他的

第六章全球电脑辅助诊断市场（按应用）

  • 概述
  • 乳癌
  • 肺癌
  • 摄护腺癌
  • 阿兹海默症
  • 糖尿病视网膜病变
  • 其他的

7. 全球电脑辅助诊断市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 其他的
    • 拉丁美洲
    • 中东和非洲

8. 全球电脑辅助诊断市场竞争格局

  • 概述
  • 各公司市场排名
  • 重点发展策略

第九章 公司简介

  • Hitachi High Technologies Corporation
  • Vucomp
  • Siemens Healthcare
  • EDDA Technology, Inc.
  • McKesson Corporation
  • iCAD, Inc.

第十章 重大进展

  • 产品发布/开发
  • 合併与收购
  • 业务扩展
  • 伙伴关係与合作

第十一章 附录

  • 相关调查
简介目录
Product Code: 33698

Computer Aided Diagnosis Market Size And Forecast

Computer Aided Diagnosis Market size was valued at USD 792.33 Million in 2024 and is projected to reach USD 1211.21 Million by 2032, growing at a CAGR of 6.01% from 2026 to 2032.

Global Computer Aided Diagnosis Market Drivers

The market drivers for the Computer Aided Diagnosis Market can be influenced by various factors. These may include:

Technological Advancements: The accuracy and efficiency of CAD systems are being improved by ongoing developments in artificial intelligence (AI) algorithms and imaging modalities (such as MRI, CT scans, and X-rays), which is propelling market expansion.

Growing Prevalence of Chronic Diseases: Early and accurate diagnosis is necessary due to the rising prevalence of chronic diseases such as cancer, cardiovascular disease, and neurological disorders. CAD systems can offer this, which is boosting demand in the market.

Growing Aging Population: As the world's population ages, age-related diseases-which frequently call for diagnostic imaging-are more common. CAD systems promote market expansion by assisting in the early diagnosis and detection of such problems.

for Non-Invasive Diagnostic Procedures: By providing non-invasive diagnostic options, computer-aided diagnostic systems (CAD) lessen patient discomfort and the possibility of invasive procedure-related problems. This is what propels the use of CAD technology, especially in fields like breast cancer detection.

Government financing and Initiatives: The use of CAD systems can be increased by providing financing and encouraging the development of healthcare infrastructure, particularly in emerging economies.

Growing Healthcare Expenditure: The global increase in healthcare spending, particularly in industrialized nations, allows medical facilities to purchase sophisticated diagnostic tools such as computer-aided diagnosis (CAD) systems.

Requirement for Efficient Delivery of Healthcare: CAD systems reduce diagnostic mistakes and streamline the diagnostic process, enhancing workflow efficiency for healthcare practitioners. The adoption of CAD technology is driven by the demand for efficiency in the delivery of healthcare.

Education and Awareness Campaigns: Raising patient and healthcare provider acceptance of CAD systems is facilitated by education campaigns about the advantages of early diagnosis and technological improvements in medical imaging.

Integration with Electronic Health Records (EHR) Systems: The smooth exchange of information and decision-making that results from the integration of CAD and EHR systems improves data accessibility and interoperability and propels market expansion.

Global Computer Aided Diagnosis Market Restraints

Several factors can act as restraints or challenges for the Computer Aided Diagnosis Market. These may include:

High expenditures: The initial investment for CAD systems is frequently substantial and includes expenditures for training, software, and hardware. Healthcare facilities may find this high implementation cost to be a significant obstacle, especially in poor nations or smaller establishments.

Integration Challenges: It can be difficult and expensive to integrate CAD systems with the current healthcare infrastructure, which includes picture archiving and communication systems (PACS) and electronic health records (EHR). Adoption rates may be slowed by compatibility problems and interoperability difficulties.

Regulatory Obstacles: There are strict regulations governing CAD systems used in medical diagnostics, especially with regard to data privacy, safety, and efficacy. The process of obtaining regulatory approval can be costly and time-consuming, which delays the introduction of new ideas and products onto the market.

Limited Clinical Evidence: Although CAD technology has advanced, there may not be enough solid clinical evidence to support its value in enhancing patient outcomes or diagnostic accuracy. Healthcare providers may be reluctant to widely implement CAD systems as a result of this uncertainty.

Dependency on Expertise: CAD systems frequently use algorithms that have been trained using expert-curated datasets. The accuracy and dependability of CAD algorithms are, however, affected by the quality and representativeness of these datasets, which can differ, especially when it comes to rare diseases or varied patient populations.

Workflow Disruption: Integrating CAD systems into clinical workflows may cause established procedures to change, and medical professionals may need to receive training in order to use the technology properly. Adoption rates may be slowed by healthcare workers' resistance to change and worries about interruptions to workflow.

Data Security Issues: Because CAD systems handle vast amounts of private patient data, there are issues with data security, privacy, and possible breaches. For CAD vendors and healthcare institutions, maintaining patient information security and compliance with data protection standards can be difficult yet necessary.

Global Computer Aided Diagnosis Market: Segmentation Analysis

The Global Computer Aided Diagnosis Market is Segmented on the basis of Imaging Modalities, Application, And Geography.

Computer Aided Diagnosis Market, By Imaging Modalities

  • Mammography
  • Nuclear Imaging
  • Ultrasound Imaging
  • Magnetic Resonance Imaging
  • Others

Based on Imaging Modalities, the market is segmented into Mammography, Nuclear Imaging, Ultrasound Imaging, Magnetic Resonance Imaging, and Others. The segment is expected to hold the largest market share. These factors can be attributed to the growing incidence of cancer all over the world. According to the World Cancer Research Fund International 2012, North America and Oceania have the highest breast cancer rate.

Computer Aided Diagnosis Market, By Application

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Alzheimer's Disease
  • Diabetic Retinopathy
  • Others

Based on Application, the market is segmented into Breast Cancer, Lung Cancer, Prostate Cancer, Alzheimer's disease, Diabetic Retinopathy, and Others. The Breast Cancer segment is anticipated to have the highest CAGR in the forecasted period. The factors can be attributed to the rising awareness of regular breast cancer check-ups and the increasing prevalence of cancer.

Computer Aided Diagnosis Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on Regional Analysis, the Global Computer Aided Diagnosis Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share of the market will be dominated by North America owing to shifting trends from image analysis & pattern recognition algorithms to workflow management functions for diseases & conditions and ongoing research & development in this segment. The Asia Pacific is expected to grow at the highest CAGR due to increasing government initiatives, an upsurge in the demand for medical tourism, and the growing cost-effective technologies in this region.

Key Players

  • The major players in the Computer Aided Diagnosis Market are:
  • Hologic
  • AdvancedMD, Inc.
  • Median Technologies
  • Philips N.V.
  • Canon Medical Systems
  • Hitachi High Technologies Corporation
  • Vucomp
  • Siemens Healthcare
  • EDDA Technology Inc.
  • McKesson Corporation
  • iCAD Inc

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL COMPUTER AIDED DIAGNOSIS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET, BY IMAGING MODALITIES

  • 5.1 Overview
  • 5.2 Mammography
  • 5.3 Nuclear Imaging
  • 5.4 Ultrasound Imaging
  • 5.5 Magnetic Resonance Imaging
  • 5.6 Others

6 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Breast Cancer
  • 6.3 Lung Cancer
  • 6.4 Prostate Cancer
  • 6.5 Alzheimer's Disease
  • 6.6 Diabetic Retinopathy
  • 6.7 Others

7 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Hitachi High Technologies Corporation
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Vucomp
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Siemens Healthcare
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 EDDA Technology, Inc.
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 McKesson Corporation
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 iCAD, Inc.
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments

10 KEY DEVELOPMENTS

  • 10.1 Product Launches/Developments
  • 10.2 Mergers and Acquisitions
  • 10.3 Business Expansions
  • 10.4 Partnerships and Collaborations

11 Appendix

  • 11.1 Related Research